SS
JAZZ icon

Sunbelt Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sunbelt Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-400
Closed -$52.7K – 2870
2025
Q3 		$52.7K Buy
+400
New +$48K ﹤0.01% 986
2024
Q4 		– Sell
-4
Closed -$446 – 1868
2024
Q3 		$446 Hold
4
– – ﹤0.01% 1744
2024
Q2 		$427 Hold
4
– – ﹤0.01% 1666
2024
Q1 		$482 Hold
4
– – ﹤0.01% 1629
2023
Q4 		$492 Hold
4
– – ﹤0.01% 1596
2023
Q3 		$518 Hold
4
– – ﹤0.01% 1652
2023
Q2 		$496 Hold
4
– – ﹤0.01% 1584
2023
Q1 		$580 Buy
+4
New +$592 ﹤0.01% 1539

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sunbelt Securities's JAZZ Position: Q4 2025 in Review

Sunbelt Securities sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2025, closing a stake of 400 shares — an estimated $52.7K sold.

Sunbelt Securities first reported a position in JAZZ in Q1 2023 and held it in 8 quarters. The position peaked at $52.7K in Q3 2025. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

  • Sunbelt Securities reported no remaining Jazz Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Sunbelt Securities sold 400 Jazz Pharmaceuticals shares in Q4 2025, an estimated $52.7K.
  • Sunbelt Securities first reported a position in Jazz Pharmaceuticals in Q1 2023 and held it in 8 quarters.
  • Sunbelt Securities's Jazz Pharmaceuticals position peaked at $52.7K in Q3 2025.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on Sunbelt Securities's 13F filing for Q4 2025, filed 20 Feb 2026.